NCT06259487 (VACCINE-CHF) is a NA clinical trial of Coordinated Vaccination in Heart Failure, sponsored by Wroclaw Medical University.

Who is sponsoring NCT06259487?

NCT06259487 is sponsored by Wroclaw Medical University.

What drugs are being tested in NCT06259487?

Interventions in NCT06259487: Coordinated Vaccination, Following recommendations.

What condition does NCT06259487 study?

NCT06259487 studies Heart Failure, RSV Infection, Influenza, Vaccines.

Is NCT06259487 still recruiting?

NCT06259487 is currently status unknown. Last updated 14 February 2024.

Last reviewed 2024-02-14 · How we verify

NCT06259487: VACCINE-CHF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.

Status unknown NA Last updated 14 February 2024

What this trial tests

NA trial testing Coordinated Vaccination in Heart Failure in 250 participants. Status unknown.

Timeline

15 September 2023

Primary endpoint
30 June 2024

30 July 2024

Quick facts

Lead sponsor	Wroclaw Medical University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	250
Start date	15 September 2023
Primary completion	30 June 2024
Estimated completion	30 July 2024
Sites	1 location across Poland

Drugs / interventions tested

Coordinated Vaccination — full drug profile →
Following recommendations

Conditions studied

Heart Failure — all drugs for Heart Failure →
RSV Infection — all drugs for RSV Infection →
Influenza — all drugs for Influenza →
Vaccines — all drugs for Vaccines →

Sponsor

Wroclaw Medical University

Who can join

18 and older, any sex, with Heart Failure or RSV Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective, single-centre, open-label, randomized study aims to determine whether coordinated care in administering protective vaccinations (against Respiratory Syncytial Virus (RSV) and influenza) impacts the prognosis of patients with chronic heart failure. The main question it aims to answer is: • Does coordinated care through vaccinations improve the prognosis of patients with chronic heart failure?

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Simultaneous vaccination against influenza and respiratory syncytial virus in high-risk heart failure patients.
Biegus J, Szenborn L, Tkaczyszyn M, Zymlinski R, et al · · 2025 · cited 1× · PMID 40998567 · DOI 10.1002/ehf2.15432

Verify or expand the search:

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting

Other Wroclaw Medical University trials

Trials by the same sponsor.

NCT07413419 — Evaluation of Remote Motivational Interviewing for Disease Management in Heart Failure Patients and Their Carers · NA · not yet recruiting
NCT07159932 — Poland Integrated Medicines Management (PL-IMM) - Study Assessing the Provision of Complex Clinical Pharmacy Services to · NA · not yet recruiting
NCT07141745 — Electroporation vs. Radiofrequency Ablation Guided by 3D Imaging in Repeat Procedures for Atrial Fibrillation · NA · recruiting
NCT07099885 — Simple Urine Composition-based Personalized Algorithm for Effective Congestion Relief in Decompensated Heart Failure · NA · recruiting
NCT07157475 — Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06259487 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wroclaw Medical University
Last refreshed: 14 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06259487.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing